Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Barton, C. C.
Right arrow Articles by Roth, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barton, C. C.
Right arrow Articles by Roth, R. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 58, 208-215 (2000)
Copyright © 2000 by the Society of Toxicology

Systems Toxicology

Lipopolysaccharide Augments Aflatoxin B1-Induced Liver Injury through Neutrophil-Dependent and -Independent Mechanisms

C. Charles Barton, Patricia E. Ganey and Robert A. Roth1

Department of Pharmacology and Toxicology, National Food Safety and Toxicology Center, and Institute for Environmental Toxicology, Michigan State University, East Lansing, Michigan 48824

Exposure to small, noninjurious doses of the inflammagen, bacterial endotoxin (lipopolysaccharide, LPS) augments the toxicity of certain hepatotoxicants including aflatoxin B1 (AFB1). Mediators of inflammation, in particular neutrophils (PMNs), are responsible for tissue injury in a variety of animal models. This study was conducted to examine the role of PMNs in the pathogenesis of hepatic injury after AFB1/LPS cotreatment. Male, Sprague-Dawley rats (250–350 g) were treated with either 1 mg AFB1/kg, ip or its vehicle (0.5% DMSO/saline), and 4 h later with either E. coli LPS (7.4 x 106 EU/kg, iv) or its saline vehicle. Over a course of 6 to 96 h after AFB1 administration, rats were killed and livers were stained immunohistochemically for PMNs. LPS resulted in an increase in PMN accumulation in the liver that preceded the onset of liver injury. To assess if PMNs contributed to the pathogenesis, an anti-PMN antibody was administered to reduce PMN numbers in blood and liver, and injury was evaluated. Hepatic parenchymal cell injury was evaluated as increased alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities in serum and from histologic examination of liver sections. Biliary tract alterations were evaluated as increased concentration of serum bile acids and activities of {gamma}-glutamyltransferase (GGT), alkaline phosphatase (ALP), and 5`-nucleotidase (5`-ND) in serum. Neutrophil depletion protected against hepatic parenchymal cell injury caused by AFB1/LPS cotreatment but not against markers of biliary tract injury. This suggests that LPS augments AFB1 hepatotoxicity through two mechanisms: one of which is PMN-dependent, and another that is not.

Key Words: lipopolysaccharide; LPS; endotoxin; aflatoxin B1; sepsis; liver injury; sensitivity to intoxication; inflammation; neutrophil; PMN; hepatotoxicity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
J. P. Luyendyk, P. J. Shaw, C. D. Green, J. F. Maddox, P. E. Ganey, and R. A. Roth
Coagulation-Mediated Hypoxia and Neutrophil-Dependent Hepatic Injury in Rats Given Lipopolysaccharide and Ranitidine
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1023 - 1031.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. P. Luyendyk, J. F. Maddox, G. N. Cosma, P. E. Ganey, G. L. Cockerell, and R. A. Roth
Ranitidine Treatment during a Modest Inflammatory Response Precipitates Idiosyncrasy-Like Liver Injury in Rats
J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 9 - 16.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. A. Roth, J. P. Luyendyk, J. F. Maddox, and P. E. Ganey
Inflammation and Drug Idiosyncrasy--Is There a Connection?
J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 1 - 8.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. B. Yee, U. M. Hanumegowda, J. A. Hotchkiss, P. E. Ganey, and R. A. Roth
Role of Neutrophils in the Synergistic Liver Injury from Monocrotaline and Bacterial Lipopolysaccharide Exposure
Toxicol. Sci., March 1, 2003; 72(1): 43 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. P. Luyendyk, B. L. Copple, C. C. Barton, P. E. Ganey, and R. A. Roth
Augmentation of Aflatoxin B1 Hepatotoxicity by Endotoxin: Involvement of Endothelium and the Coagulation System
Toxicol. Sci., March 1, 2003; 72(1): 171 - 181.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. P. Luyendyk, K. C. Shores, P. E. Ganey, and R. A. Roth
Bacterial Lipopolysaccharide Exposure Alters Aflatoxin B1 Hepatotoxicity: Benchmark Dose Analysis for Markers of Liver Injury
Toxicol. Sci., July 1, 2002; 68(1): 220 - 225.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.